Correlations between antibody immune responses at different mucosal effector sites are controlled by antigen type and dosage

被引:40
作者
Externest, D [1 ]
Meckelein, B [1 ]
Schmidt, MA [1 ]
Frey, A [1 ]
机构
[1] Univ Munster, Zentrum Mol Biol Entzundung, Inst Infektiol, D-48129 Munster, Germany
关键词
D O I
10.1128/IAI.68.7.3830-3839.2000
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Monitoring specific secretory immunoglobulin A (IgA) responses in the intestines after mucosal immunization or infection is impeded by the fact that sampling of small intestinal secretions requires invasive methods not feasible for routine diagnostics. Since IgA plasma cells generated after intragastric immunization are known to populate remote mucosal sites as well, secretory IgA responses at other mucosal surfaces may correlate to those in the intestines and could serve as proxy measures for IgA secretion in the gut. To evaluate the practicability of this approach, mice were immunized intragastrically with 0.2, 2, and 20 mg of ovalbumin plus 10 mu g of cholera toxin, and the antigen-specific local secretory IgA. responses in duodenal, ileal, jegunal, rectal, and vaginal secretions, saliva, urine, and feces, as well as serum Ige and IgA responses were analyzed by enzyme-linked immunosorbent assay. Correlation analysis revealed significant relationships between serum Ige and Igh urinary IgA, salivary IgA, and secretory IgA in duodenal, jejunal, ileal, and rectal secretions for the 0.2-mg but not for the 20-mg ovalbumin dose. Fecal samples were poor predictors for intestinal anti-ovalbumin IgA responses, and no correlations could be established for cholera toxin, neither between local anti-cholera toxin levels nor to the antiovalbumin responses. Thus, specific IgA. in serum, saliva, or urine can serve as a predictor of the release of specific IgA. at intestinal surfaces after intragastric immunization, but the lack of correlations for high ovalbumin doses and for cholera toxin indicates a strong dependency on antigen type and dosage for these relationships.
引用
收藏
页码:3830 / 3839
页数:10
相关论文
共 33 条
[1]  
Ahren C, 1995, VACCINE, V13, P1754
[2]  
BARTON JR, 1990, ADVANCES IN MUCOSAL IMMUNOLOGY, P495
[3]   DEMONSTRATION OF SPECIFIC IGA IN HUMAN FECES AFTER IMMUNIZATION WITH LIVE TY21A SALMONELLA-TYPHI VACCINE [J].
CANCELLIERI, V ;
FARA, GM .
JOURNAL OF INFECTIOUS DISEASES, 1985, 151 (03) :482-484
[4]  
ELSON CO, 1984, J IMMUNOL, V133, P2892
[5]   A LAVAGE TECHNIQUE ALLOWING REPEATED MEASUREMENT OF IGA ANTIBODY IN MOUSE INTESTINAL SECRETIONS [J].
ELSON, CO ;
EALDING, W ;
LEFKOWITZ, J .
JOURNAL OF IMMUNOLOGICAL METHODS, 1984, 67 (01) :101-108
[6]  
FARIA AMC, 1993, IMMUNOLOGY, V78, P147
[7]  
FERGUSON A, 1995, CLIN EXP IMMUNOL, V99, P70
[8]   EFFECTS OF SAMPLE PROCESSING ON THE MEASUREMENT OF SPECIFIC INTESTINAL IGA IMMUNE-RESPONSES [J].
FORREST, BD .
VACCINE, 1992, 10 (11) :802-805
[9]   A statistically defined endpoint titer determination method for Immunoassays [J].
Frey, A ;
Di Canzio, J ;
Zurakowski, D .
JOURNAL OF IMMUNOLOGICAL METHODS, 1998, 221 (1-2) :35-41
[10]   A stable and highly sensitive 3,3′,5,5′-tetramethylbenzidine-based substrate reagent for enzyme-linked immunosorbent assays [J].
Frey, A ;
Meckelein, B ;
Externest, D ;
Schmidt, MA .
JOURNAL OF IMMUNOLOGICAL METHODS, 2000, 233 (1-2) :47-56